1. Hepatitis C policy development workshop. Chris Kelly. Asst. head of Health and Justice NHS England, 17/11/2014

2. Delivering services in secure and detained settings. Healthcare teams in prisons/detention centres should achieve hepatitis B vaccine coverage of over 80% for all eligible prisoners/detainees received into the establishment within 4 weeks from arrival date. Healthcare teams in prisons/detention centres should achieve an uptake of hepatitis B testing (HBsAg) of over 30% for all eligible prisoners/detainees. Referral to and assessment by the specialist Healthcare teams in prisons/detention centres: NHS | Presentation to [XXXX Company] | [Type Date]2

3. Ambition. Optimise current testing delivery with a view to achieving 100% roll out of ‘opt out’ testing across the secure and detained estate. Healthcare teams to achieve an up-take of over 30% for all eligible prisoners / detainees received into the establishment within 4 weeks from arrival Current levels if testing for HCV in prisons in England at an all time high but still not high enough and still disparate across the estate. NHS | Presentation to [XXXX Company] | [Type Date]3

4. Governance requirements. Policy review. Governance Cross partnerships. Commissioning. Co-commissioning and inter and external organisational commissioning responsibilities. Finance. Risk Road map for process for Pathfinders Benefits realisation. National Performance management through Health and Justice Indicators of Performance. (HJIP’s) NHS | Presentation to [XXXX Company] | [Type Date]4

5. Commissioning Challenges. Impact analysis. Shaping the money around demand not demand around the money. Scoping and developing with a constrained budget. What do we stop doing? Staff skills development. Workforce availability both within prisons and secondary care centres: In reach vs outreach. Continuity of care. 5NHS | Presentation to NHS England | 24/04/2014

6. Commissioning Opportunities. Reducing health inequalities across most vulnerable patient group. Contributing to the reduction of premature deaths. Cost savings of BBV care further down the care pathway through early identification and intervention. Patient safety management and reducing risk of ongoing transmission. Building on improved pathways that exist in some areas/prisons NHS | Presentation to NHS England | 24/04/20146

7. Policy development for secure and detained, NHS | Presentation to [XXXX Company] | [Type Date]7 BBV Opt out testing PID for secure and Detained. Hepatitis C improvement Framework 5 year plan Health and Justice Commissioning Intentions 15/16 Specialised Commissioning Intentions 15/16 Tripartite Partnership agreement between NHS England PHE and NOMS.